ATP induces protein arginine deiminase 2-dependent citrullination in mast cells through the P2X7 purinergic receptor

Journal of Immunology

Volumn 189, Issue 8, 2012, Pages 4112-4122

  Arandjelovic, Sanja ^a   McKenney, Katherine R ^a   Leming, Sunamita S ^a   Mowen, Kerri A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMTS9 PROTEIN; ADENOSINE TRIPHOSPHATE; INTERLEUKIN 13; INTERLEUKIN 6; METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN ARGININE DEIMINASE; PROTEIN ARGININE DEIMINASE 2; PROTEIN KINASE C; PURINERGIC P2X7 RECEPTOR; RAB PROTEIN; RAB6B PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SUBSTRATE; EXTRACELLULAR SPACE; GENE EXPRESSION REGULATION; MAST CELL; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CITRULLINATION; PROTEIN PROCESSING; PROTEIN SECRETION; SIGNAL TRANSDUCTION; UPREGULATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; CELL LINE, TUMOR; CELLS, CULTURED; CITRULLINE; EXTRACELLULAR SPACE; INFLAMMATION MEDIATORS; MAST CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEIN-ARGININE N-METHYLTRANSFERASES; RECEPTORS, PURINERGIC P2X7; SUBSTRATE SPECIFICITY;

EID: 84867295612     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201098     Document Type: Article

References (76)

1. Vossenaar, E. R., A. J. Zendman, W. J. van Venrooij, and G. J. Pruijn. 2003. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 25: 1106-1118. (Pubitemid 37411770)
2. Jones, J. E., C. P. Causey, B. Knuckley, J. L. Slack-Noyes, and P. R. Thompson. 2009. Protein arginine deiminase 4 (PAD4): current understanding and future therapeutic potential. Curr. Opin. Drug Discov. Devel. 12: 616-627.
3. Atarashi, K., J. Nishimura, T. Shima, Y. Umesaki, M. Yamamoto, M. Onoue, H. Yagita, N. Ishii, R. Evans, K. Honda, and K. Takeda. 2008. ATP drives lamina propria T(H)17 cell differentiation. Nature 455: 808-812.
4. Kono, H., and K. L. Rock. 2008. How dying cells alert the immune system to danger. Nat. Rev. Immunol. 8: 279-289. (Pubitemid 351432799)
5. Donnelly-Roberts, D. L., M. T. Namovic, P. Han, and M. F. Jarvis. 2009. Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors. Br. J. Pharmacol. 157: 1203-1214.
6. Lister, M. F., J. Sharkey, D. A. Sawatzky, J. P. Hodgkiss, D. J. Davidson, A. G. Rossi, and K. Finlayson. 2007. The role of the purinergic P2X7 receptor in inflammation. J. Inflamm. (Lond.) 4: 5.
7. Skaper, S. D., P. Debetto, and P. Giusti. 2010. The P2X7 purinergic receptor: from physiology to neurological disorders. FASEB J. 24: 337-345.
8. Schroder, K., and J. Tschopp. 2010. The inflammasomes. Cell 140: 821-832.
9. Hanley, P. J., M. Kronlage, C. Kirschning, A. del Rey, F. Di Virgilio, J. Leipziger, I. P. Chessell, S. Sargin, M. A. Filippov, O. Lindemann, et al. 2012. Transient P2X7 receptor activation triggers macrophage death independent of Toll-like receptors 2 and 4, caspase-1, and pannexin-1 proteins. J. Biol. Chem. 287: 10650-10663.
10. Monif, M., C. A. Reid, K. L. Powell, M. L. Smart, and D. A. Williams. 2009. The P2X7 receptor drives microglial activation and proliferation: a trophic role for P2X7R pore. J. Neurosci. 29: 3781-3791.
11. Raptopoulou, A., P. Sidiropoulos, M. Katsouraki, and D. T. Boumpas. 2007. Anti-citrulline antibodies in the diagnosis and prognosis of rheumatoid arthritis: evolving concepts. Crit. Rev. Clin. Lab. Sci. 44: 339-363. (Pubitemid 46897707)
12. Foulquier, C., M. Sebbag, C. Clavel, S. Chapuy-Regaud, R. Al Badine, M. C. Méchin, C. Vincent, R. Nachat, M. Yamada, H. Takahara, et al. 2007. Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation. Arthritis Rheum. 56: 3541-3553. (Pubitemid 350100687)
13. Nakayama-Hamada, M., A. Suzuki, K. Kubota, T. Takazawa, M. Ohsaka, R. Kawaida, M. Ono, A. Kasuya, H. Furukawa, R. Yamada, and K. Yamamoto. 2005. Comparison of enzymatic properties between hPADI2 and hPADI4. Biochem. Biophys. Res. Commun. 327: 192-200. (Pubitemid 40051370)
14. Galli, S. J., J. Kalesnikoff, M. A. Grimbaldeston, A. M. Piliponsky, C. M. Williams, and M. Tsai. 2005. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol. 23: 749-786. (Pubitemid 40563184)
15. Solle, M., J. Labasi, D. G. Perregaux, E. Stam, N. Petrushova, B. H. Koller, R. J. Griffiths, and C. A. Gabel. 2001. Altered cytokine production in mice lacking P2X(7) receptors. J. Biol. Chem. 276: 125-132. (Pubitemid 32050297)
16. Arandjelovic, S., D. Wickramarachchi, S. Hemmers, S. S. Leming, D. H. Kono, and K. A. Mowen. 2010. Mast cell function is not altered by Coronin-1A deficiency. J. Leukoc. Biol. 88: 737-745.
17. Terakawa, H., H. Takahara, and K. Sugawara. 1991. Three types of mouse peptidylarginine deiminase: characterization and tissue distribution. J. Biochem. 110: 661-666.
18. Nigrovic, P. A., and D. M. Lee. 2005. Mast cells in autoantibody responses and arthritis. Novartis Found. Symp. 271: 200-209, discussion 210-204.
19. Raijmakers, R., J. Vogelzangs, J. Raats, M. Panzenbeck, M. Corby, H. Jiang, M. Thibodeau, N. Haynes, W. J. van Venrooij, G. J. Pruijn, and B. Werneburg. 2006. Experimental autoimmune encephalomyelitis induction in peptidylarginine deiminase 2 knockout mice. J. Comp. Neurol. 498: 217-226. (Pubitemid 44182462)
20. Sugawara, K., Y. Oikawa, and T. Ouchi. 1982. Identification and properties of peptidylarginine deiminase from rabbit skeletal muscle. J. Biochem. 91: 1065-1071.
21. Takahara, H., Y. Oikawa, and K. Sugawara. 1983. Purification and characterization of peptidylarginine deiminase from rabbit skeletal muscle. J. Biochem. 94: 1945-1953.
22. Arita, K., H. Hashimoto, T. Shimizu, K. Nakashima, M. Yamada, and M. Sato. 2004. Structural basis for Ca(2+)-induced activation of human PAD4. Nat. Struct. Mol. Biol. 11: 777-783. (Pubitemid 39014504)
23. Junger, W. G. 2011. Immune cell regulation by autocrine purinergic signalling. Nat. Rev. Immunol. 11: 201-212.
24. Hemmers, S., J. R. Teijaro, S. Arandjelovic, and K. A. Mowen. 2011. PAD4-mediated neutrophil extracellular trap formation is not required for immunity against influenza infection. PLoS ONE 6: e22043.
25. Oh-hora, M., and A. Rao. 2008. Calcium signaling in lymphocytes. Curr. Opin. Immunol. 20: 250-258.
26. Surprenant, A., and R. A. North. 2009. Signaling at purinergic P2X receptors. Annu. Rev. Physiol. 71: 333-359.
27. Hung, A. C., Y. J. Chu, Y. H. Lin, J. Y. Weng, H. B. Chen, Y. C. Au, and S. H. Sun. 2005. Roles of protein kinase C in regulation of P2X7 receptor-mediated calcium signalling of cultured type-2 astrocyte cell line, RBA-2. Cell. Signal. 17: 1384-1396. (Pubitemid 41206648)
28. Dahlquist, R., and B. Diamant. 1974. Interaction of ATP and calcium on the rat mast cell: effect on histamine release. Acta Pharmacol. Toxicol. (Copenh.) 34: 368-384.
29. Sugiyama, K. 1971. Calcium-dependent histamine release with degranulation from isolated rat mast cells by adenosine 59-triphosphate. Jpn. J. Pharmacol. 21: 209-226.
30. Bours, M. J., E. L. Swennen, F. Di Virgilio, B. N. Cronstein, and P. C. Dagnelie. 2006. Adenosine 59-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol. Ther. 112: 358-404. (Pubitemid 44486409)
31. Lee, Y. H., S. A. Coonrod, W. L. Kraus, M. A. Jelinek, and M. R. Stallcup. 2005. Regulation of coactivator complex assembly and function by protein arginine methylation and demethylimination. Proc. Natl. Acad. Sci. USA 102: 3611-3616.
32. Friedle, S. A., V. M. Brautigam, M. Nikodemova, M. L. Wright, and J. J. Watters. 2011. The P2X7-Egr pathway regulates nucleotide-dependent inflammatory gene expression in microglia. Glia 59: 1-13.
33. Shiratori, M., H. Tozaki-Saitoh, M. Yoshitake, M. Tsuda, and K. Inoue. 2010. P2X7 receptor activation induces CXCL2 production in microglia through NFAT and PKC/MAPK pathways. J. Neurochem. 114: 810-819.
34. Diaconu, N. C., R. Kaminska, A. Naukkarinen, R. J. Harvima, G. Nilsson, and I. T. Harvima. 2007. Increase in CD30 ligand/CD153 and TNF-a expressing mast cells in basal cell carcinoma. Cancer Immunol. Immunother. 56: 1407-1415. (Pubitemid 47024710)
35. Aggarwal, B. B. 2003. Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 3: 745-756. (Pubitemid 41070815)
36. Constantin, A., P. Dieudé V. Lauwers-Cancès, B. Jamard, B. Mazières, A. Cambon-Thomsen, F. Cornélis, and A. Cantagrel. 2004. Tumor necrosis factor receptor II gene polymorphism and severity of rheumatoid arthritis. Arthritis Rheum. 50: 742-747.
37. Demircan, K., S. Hirohata, K. Nishida, O. F. Hatipoglu, T. Oohashi, T. Yonezawa, S. S. Apte, and Y. Ninomiya. 2005. ADAMTS-9 is synergistically induced by interleukin-1β and tumor necrosis factor α in OUMS-27 chondrosarcoma cells and in human chondrocytes. Arthritis Rheum. 52: 1451-1460. (Pubitemid 40663937)
38. Opdam, F. J., A. Echard, H. J. Croes, J. A. van den Hurk, R. A. van de Vorstenbosch, L. A. Ginsel, B. Goud, and J. A. Fransen. 2000. The small GTPase Rab6B, a novel Rab6 subfamily member, is cell-type specifically expressed and localised to the Golgi apparatus. J. Cell Sci. 113: 2725-2735. (Pubitemid 30649574)
39. Wanschers, B., R. van de Vorstenbosch, M. Wijers, B. Wieringa, S. M. King, and J. Fransen. 2008. Rab6 family proteins interact with the dynein light chain protein DYNLRB1. Cell Motil. Cytoskeleton 65: 183-196. (Pubitemid 351323740)
40. Qu, Y., and G. R. Dubyak. 2009. P2X7 receptors regulate multiple types of membrane trafficking responses and non-classical secretion pathways. Purinergic Signal. 5: 163-173.
41. Kinloch, A., K. Lundberg, R. Wait, N. Wegner, N. H. Lim, A. J. Zendman, T. Saxne, V. Malmström, and P. J. Venables. 2008. Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis. Arthritis Rheum. 58: 2287-2295.
42. Qu, Y., L. Franchi, G. Nunez, and G. R. Dubyak. 2007. Nonclassical IL-1 β secretion stimulated by P2X7 receptors is dependent on inflammasome activation and correlated with exosome release in murine macrophages. J. Immunol. 179: 1913-1925.
43. Cockcroft, S., and B. D. Gomperts. 1979. ATP induces nucleotide permeability in rat mast cells. Nature 279: 541-542. (Pubitemid 9195267)
44. Hegmans, J. P., M. P. Bard, A. Hemmes, T. M. Luider, M. J. Kleijmeer, J. B. Prins, L. Zitvogel, S. A. Burgers, H. C. Hoogsteden, and B. N. Lambrecht. 2004. Proteomic analysis of exosomes secreted by human mesothelioma cells. Am. J. Pathol. 164: 1807-1815. (Pubitemid 38529783)
45. Wubbolts, R., R. S. Leckie, P. T. Veenhuizen, G. Schwarzmann, W. Möbius, J. Hoernschemeyer, J. W. Slot, H. J. Geuze, and W. Stoorvogel. 2003. Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J. Biol. Chem. 278: 10963-10972. (Pubitemid 36792644)
46. Sintiprungrat, K., N. Singhto, S. Sinchaikul, S. T. Chen, and V. Thongboonkerd. 2010. Alterations in cellular proteome and secretome upon differentiation from monocyte to macrophage by treatment with phorbol myristate acetate: insights into biological processes. J. Proteomics 73: 602-618.
47. Benoist, C., and D. Mathis. 2002. Mast cells in autoimmune disease. Nature 420: 875-878. (Pubitemid 36019641)
48. Schulman, E. S., M. C. Glaum, T. Post, Y. Wang, D. G. Raible, J. Mohanty, J. H. Butterfield, and A. Pelleg. 1999. ATP modulates anti-IgE-induced release of histamine from human lung mast cells. Am. J. Respir. Cell Mol. Biol. 20: 530-537. (Pubitemid 129504876)
49. Wareham, K., C. Vial, R. C. Wykes, P. Bradding, and E. P. Seward. 2009. Functional evidence for the expression of P2X1, P2X4 and P2X7 receptors in human lung mast cells. Br. J. Pharmacol. 157: 1215-1224.
50. Bulanova, E., and S. Bulfone-Paus. 2010. P2 receptor-mediated signaling in mast cell biology. Purinergic Signaling 6: 3-17.
51. Obenauer, J. C., L. C. Cantley, and M. B. Yaffe. 2003. Scansite 2.0: proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res. 31: 3635-3641. (Pubitemid 37442212)
52. Lenertz, L. Y., M. L. Gavala, Y. Zhu, and P. J. Bertics. 2011. Transcriptional control mechanisms associated with the nucleotide receptor P2X7, a critical regulator of immunologic, osteogenic, and neurologic functions. Immunol. Res. 50: 22-38.
53. Lopez-Castejon, G., J. Theaker, P. Pelegrin, A. D. Clifton, M. Braddock, and A. Surprenant. 2010. P2X(7) receptor-mediated release of cathepsins from macrophages is a cytokine-independent mechanism potentially involved in joint diseases. J. Immunol. 185: 2611-2619.
54. Labasi, J. M., N. Petrushova, C. Donovan, S. McCurdy, P. Lira, M. M. Payette, W. Brissette, J. R. Wicks, L. Audoly, and C. A. Gabel. 2002. Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response. J. Immunol. 168: 6436-6445. (Pubitemid 34620068)
55. Vossenaar, E. R., S. Nijenhuis, M. M. Helsen, A. van der Heijden, T. Senshu, W. B. van den Berg, W. J. van Venrooij, and L. A. Joosten. 2003. Citrullination of synovial proteins in murine models of rheumatoid arthritis. Arthritis Rheum. 48: 2489-2500. (Pubitemid 37129426)
56. Chang, X., R. Yamada, T. Sawada, A. Suzuki, Y. Kochi, and K. Yamamoto. 2005. The inhibition of antithrombin by peptidylarginine deiminase 4 may contribute to pathogenesis of rheumatoid arthritis. Rheumatology (Oxford) 44: 293-298.
57. Adams, R. A., C. Schachtrup, D. Davalos, I. Tsigelny, and K. Akassoglou. 2007. Fibrinogen signal transduction as a mediator and therapeutic target in inflammation: lessons from multiple sclerosis. Curr. Med. Chem. 14: 2925-2936. (Pubitemid 350201659)
58. Klareskog, L., J. Rönnelid, K. Lundberg, L. Padyukov, and L. Alfredsson. 2008. Immunity to citrullinated proteins in rheumatoid arthritis. Annu. Rev. Immunol. 26: 651-675.
59. Loos, T., A. Mortier, M. Gouwy, I. Ronsse,W. Put, J. P. Lenaerts, J. Van Damme, and P. Proost. 2008. Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally occurring posttranslational modification of chemokines and new dimension of immunoregulation. Blood 112: 2648-2656.
60. Proost, P., T. Loos, A. Mortier, E. Schutyser, M. Gouwy, S. Noppen, C. Dillen, I. Ronsse, R. Conings, S. Struyf, et al. 2008. Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation. J. Exp. Med. 205: 2085-2097.
61. Struyf, S., S. Noppen, T. Loos, A. Mortier, M. Gouwy, H. Verbeke, D. Huskens, S. Luangsay, M. Parmentier, K. Geboes, et al. 2009. Citrullination of CXCL12 differentially reduces CXCR4 and CXCR7 binding with loss of inflammatory and anti-HIV-1 activity via CXCR4. J. Immunol. 182: 666-674.
62. Hofmann, A. M., and S. N. Abraham. 2010. New roles for mast cells in pathogen defense and allergic disease. Discov. Med. 9: 79-83.
63. Kataoka, A., H. Tozaki-Saitoh, Y. Koga, M. Tsuda, and K. Inoue. 2009. Activation of P2X7 receptors induces CCL3 production in microglial cells through transcription factor NFAT. J. Neurochem. 108: 115-125.
64. Sagi-Eisenberg, R. 2007. The mast cell: where endocytosis and regulated exocytosis meet. Immunol. Rev. 217: 292-303. (Pubitemid 46718149)
65. Petersen, T. N., S. Brunak, G. von Heijne, and H. Nielsen. 2011. SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat. Methods 8: 785-786.
66. Kumar, S., P. C. McDonnell, R. Lehr, L. Tierney, M. N. Tzimas, D. E. Griswold, E. A. Capper, R. Tal-Singer, G. I. Wells, M. L. Doyle, and P. R. Young. 2000. Identification and initial characterization of four novel members of the interleukin-1 family. J. Biol. Chem. 275: 10308-10314. (Pubitemid 30202089)
67. Smith, D. E., B. R. Renshaw, R. R. Ketchem, M. Kubin, K. E. Garka, and J. E. Sims. 2000. Four new members expand the interleukin-1 superfamily. J. Biol. Chem. 275: 1169-1175. (Pubitemid 30051168)
68. MacKenzie, A., H. L. Wilson, E. Kiss-Toth, S. K. Dower, R. A. North, and A. Surprenant. 2001. Rapid secretion of interleukin-1β by microvesicle shedding. Immunity 15: 825-835. (Pubitemid 34008509)
69. Andrei, C., C. Dazzi, L. Lotti, M. R. Torrisi, G. Chimini, and A. Rubartelli. 1999. The secretory route of the leaderless protein interleukin 1β involves exocytosis of endolysosome-related vesicles. Mol. Biol. Cell 10: 1463-1475. (Pubitemid 29230902)
70. Takenouchi, T., M. Nakai, Y. Iwamaru, S. Sugama, M. Tsukimoto, M. Fujita, J. Wei, A. Sekigawa, M. Sato, S. Kojima, et al. 2009. The activation of P2X7 receptor impairs lysosomal functions and stimulates the release of autophagolysosomes in microglial cells. J. Immunol. 182: 2051-2062.
71. Johnsen, A. K., W. Valdar, L. Golden, A. Ortiz-Lopez, R. Hitzemann, J. Flint, D. Mathis, and C. Benoist. 2011. Genome-wide and species-wide dissection of the genetics of arthritis severity in heterogeneous stock mice. Arthritis Rheum. 63: 2630-2640.
72. Willis, V. C., A. M. Gizinski, N. K. Banda, C. P. Causey, B. Knuckley, K. N. Cordova, Y. Luo, B. Levitt, M. Glogowska, P. Chandra, et al. 2011. N-α-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis. J. Immunol. 186: 4396-4404.
73. Suzuki, A., R. Yamada, and K. Yamamoto. 2007. Citrullination by peptidylarginine deiminase in rheumatoid arthritis. Ann. N. Y. Acad. Sci. 1108: 323-339. (Pubitemid 47528745)
74. van der Helm-van Mil, A. H., and T. W. Huizinga. 2008. Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets. Arthritis Res. Ther. 10: 205.
75. De Rycke, L., A. P. Nicholas, T. Cantaert, E. Kruithof, J. D. Echols, B. Vandekerckhove, E. M. Veys, F. De Keyser, and D. Baeten. 2005. Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase as pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity. Arthritis Rheum. 52: 2323-2330. (Pubitemid 41117416)
76. Broom, D. C., D. J. Matson, E. Bradshaw, M. E. Buck, R. Meade, S. Coombs, M. Matchett, K. K. Ford, W. Yu, J. Yuan, et al. 2008. Characterization of N-(adamantan-1-ylmethyl)-5-[(3R-amino-pyrrolidin-1-yl)methyl]-2-chlorobenzamide, a P2X7 antagonist in animal models of pain and inflammation. J. Pharmacol. Exp. Ther. 327: 620-633.